Capricor, Inc. is a stem cell company focusing on cardiac regeneration. Led by interim CEO Linda Marbán the company is preparing for two phase I/II clinical trials in the next year. Capricor’s scientific foundation is rooted in work done in Eduardo Marbàn’s lab at Cedars-Sinai.